U.S. Residential REITs Stock News

Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and...

Agilent Technologies (A) has opened fiscal Q1 2026 with revenue of US$1.8b and basic EPS of US$1.08, setting the tone against a trailing twelve month picture that shows US$7.1b in revenue and EPS of US$4.55. Over the past year, the company has seen quarterly revenue move from US$1.70b in Q4 2024 to US$1.86b in Q4 2025 and then to US$1.80b in Q1 2026. Basic EPS shifted from US$1.23 to US$1.53 and now US$1.08, leaving investors focused on how the 18.3% trailing net margin shapes the quality of...

If you are wondering whether Stagwell is attractively priced or just cheap for a reason, you are in the right place to get a clearer view of what the current share price might actually represent. The stock closed at US$4.85 recently, with a 2.3% gain over the last 7 days, a 21.5% decline over the past month, and returns of 2.5% year to date, but a 23.7% decline over the past year and a 36.0% decline over three years. Recent coverage of Stagwell has focused on broader media and marketing...

Globus Medical (GMED) just closed out FY 2025 with Q4 revenue of US$826.4 million and basic EPS of US$1.05. Trailing twelve month revenue reached about US$2.9 billion and EPS came in at US$3.98, setting the stage for a sharply different earnings profile compared with a year earlier. Over the past six quarters, the company has seen quarterly revenue move from US$625.7 million in Q3 2024 to US$826.4 million in Q4 2025, with basic EPS shifting from US$0.38 to US$1.05 across the same period. This...

Excelerate Energy (EE) has wrapped up FY 2025 with fourth quarter revenue of US$317.6 million, basic EPS of US$0.29 and net income of US$9.1 million. Trailing twelve month revenue sits at about US$1.2 billion, with basic EPS of US$1.31 and net income of US$39.2 million. The company has seen quarterly revenue move from US$274.6 million in Q4 2024 to US$317.6 million in Q4 2025. EPS has run between US$0.15 and US$0.48 over the last four reported quarters. These headline numbers can be weighed...

Essential Utilities (WTRG) has wrapped up FY 2025 with fourth quarter revenue of US$699.1 million and basic EPS of US$0.47, alongside trailing 12 month revenue of US$2.5 billion and EPS of US$2.20, setting a clear earnings picture for investors to work with. The company has seen revenue move from US$2.1 billion and EPS of US$2.17 on a trailing basis in Q4 2024 to US$2.5 billion and EPS of US$2.20 in Q4 2025, while quarterly revenue has shifted from US$604.4 million a year ago to US$699.1...

Sarepta Therapeutics (SRPT) closed out FY 2025 with Q4 revenue of US$442.9 million and a basic EPS loss of US$3.93, alongside a full year trailing net loss of US$713.4 million on US$2.2 billion of revenue. Over the last six quarters in the data, revenue has ranged from US$399.4 million to US$744.9 million per quarter. Basic EPS has swung between a profit of US$2.01 and a loss of US$4.60, highlighting sharp shifts in margins that keep profitability firmly in focus for investors. See our full...

HNI stock performance snapshot and business context HNI (HNI) has recently seen mixed share performance, with a 1 day decline of 1.17% and a 9.15% drop over the past week, while returns over the past 3 months remain positive. For context, the company reports annual revenue of US$2.84b and net income of US$54.2m, with recent annual revenue and net income growth figures of 32.84% and 55.29%, respectively. See our latest analysis for HNI. HNI’s recent share price softness, including a 9.15% 7...

Starboard’s activist push and Tripadvisor’s response Tripadvisor (TRIP) is in focus after activist investor Starboard Value moved to nominate a majority slate of new directors. Starboard has criticized the company’s board, past decisions, and pace of change. Tripadvisor responded by highlighting ongoing talks with Starboard. The company reiterated that it engages with shareholders, is reshaping its operating model around Experiences, and is assessing options it believes can support long term...

ZipRecruiter FY 2025 earnings snapshot ZipRecruiter (ZIP) has wrapped up FY 2025 with fourth quarter revenue of US$111.7 million and a basic EPS loss of US$0.01, setting the tone for a year where profitability stayed out of reach. Over recent periods, the company has seen quarterly revenue move from US$110.1 million in Q1 2025 to US$114.98 million in Q3 2025. Basic EPS losses ranged from US$0.13 in Q1 to US$0.11 in Q3 and US$0.01 in Q4, keeping margins under pressure. For investors, the focus...

Why H2O America’s latest earnings matter for investors H2O America (HTO) just posted its fourth quarter and full year 2025 results, pairing higher annual sales and net income with a much larger 2026 to 2030 capital spending plan and an increased long term EPS growth target. See our latest analysis for H2O America. H2O America shares trade at US$54.00 after a 16.3% 90 day share price return and a 6.8% 1 year total shareholder return. This suggests recent momentum has improved compared with the...

Why Progressive’s latest update is drawing attention Progressive (PGR) is back in focus after January 2026 results showed higher net premiums written, higher net premiums earned, and a 10% rise in total policies in force, especially in agency and direct auto. Some analysts cut their price targets after net investment income came in below forecasts, while keeping overall ratings in the positive to neutral range. The upcoming annual report and March 3 investor event are now key watchpoints. See...

Net Lease Office Properties (NLOP) just wrapped up FY 2025 with Q4 total revenue of US$30.7 million, Funds From Operations of a US$44.6 million loss, and basic EPS of a US$0.00 loss, alongside Q4 net income excluding extra items of essentially breakeven at a US$0.05 million loss. Over recent quarters, revenue has moved between US$27.7 million in Q4 2024 and US$30.7 million in Q4 2025, while quarterly EPS ranged from a profit of US$0.03 in Q1 2025 to a loss of US$5.50 in Q2 2025, underscoring...

Encore Capital Group (ECPG) just closed FY 2025 with Q4 revenue of US$473.6 million and basic EPS of US$3.43, backed by net income of US$76.7 million for the quarter. The company has seen quarterly revenue move from US$265.6 million in Q4 2024 and US$367.1 million in Q3 2024 to US$392.8 million, US$442.1 million, US$460.4 million and now US$473.6 million across the four quarters of 2025, while EPS shifted from a loss of US$9.42 in Q4 2024 to positive prints of US$1.96, US$2.50, US$3.22 and...

If you are wondering whether Archer Aviation's current share price lines up with its long term potential, this article will walk through what the numbers are actually saying about value. The stock last closed at US$7.38, with a 2.1% return over the past 7 days, an 8.8% decline over 30 days, a 9.2% decline year to date, a 6.8% decline over 1 year, a very large 3 year return, and a 31.5% decline over 5 years, which together may leave you questioning how the recent price levels square with the...

In February 2026, Balmain Beauty, in partnership with Estée Lauder Companies, launched Destin de Balmain, a refillable prestige fragrance available globally in multiple bottle sizes and travel format. This bold debut extends Estée Lauder’s luxury fragrance portfolio at a time when product innovation and brand collaborations are key levers for reinforcing its position in prestige beauty. We’ll now examine how this debut Balmain fragrance, alongside recent earnings strength, may influence...

If you are trying to figure out whether Liquidia's share price fairly reflects its potential, starting with a clear look at valuation can help you frame that question more confidently. The stock has been volatile recently, with a 12.2% decline over the last 7 days and a 27.5% decline over the last 30 days, even though the 1 year return is 100.5% and the 3 year return is 328.8%. These sharp swings have arrived alongside ongoing investor attention on Liquidia's position in the pharmaceuticals...

Bloom Energy (NYSE:BE) has entered a $5b partnership with Brookfield Corporation. The agreement focuses on supplying fuel cell power solutions to AI data centers. The deal reflects growing demand for onsite, bring your own power setups in AI infrastructure. Bloom Energy builds solid oxide fuel cell systems that generate onsite electricity, targeting customers that need reliable, cleaner power with tight uptime requirements. With AI data centers scaling their computing capacity, power...

Atlantic Union Bankshares (NYSE:AUB) has appointed Alexander D. Dodd as Chief Financial Officer. Dodd succeeds longtime CFO Robert M. Gorman, who served in the role for nearly 14 years. The company is planning a structured transition that includes an advisory period for Gorman. For investors watching Atlantic Union Bankshares at a share price of $39.51, a CFO transition of this kind is a meaningful leadership event. With Robert M. Gorman stepping aside after nearly 14 years and Alexander D...

Alphatec Holdings (ATEC) closed out FY 2025 with Q4 revenue of US$212.9 million and a basic EPS loss of US$0.14, alongside net income excluding extra items of a US$21.7 million loss, setting a clear snapshot of where the business stands on growth and profitability. The company has seen quarterly revenue move from US$150.7 million in Q3 2024 to US$196.5 million in Q3 2025, and then to US$212.9 million in Q4 2025. Basic EPS losses shifted from US$0.28 in Q3 2024 to US$0.19 in Q3 2025 and...

If you are wondering whether IRADIMED's current share price offers good value or is already pricing in a lot of optimism, you are in the right place. The stock last closed at US$100.50, with returns of 0.4% over 30 days, 5.2% year to date, 83.1% over 1 year, 170.0% over 3 years and 371.2% over 5 years. These figures may have changed how investors think about both its potential and its risks. Recent news coverage has focused on IRADIMED's position in medical technology and its role in...

If you are wondering whether Duolingo's current share price fairly reflects its potential, you are not alone. This article is aimed at helping you weigh what you are really paying for the business. Over the last week the stock returned 5.7%, but that sits against a 19.6% decline over 30 days, a 33.4% decline year to date, and a 68.7% decline over the past year, with a 3 year return of a 2.0% decline. These moves have arrived alongside ongoing interest in language learning platforms and wider...

If you are wondering whether Asbury Automotive Group's current share price lines up with its underlying worth, this article walks through what the numbers are actually saying about value. After reaching a recent close of US$218.33, the stock has seen a 2.2% decline over the last 7 days, a 9.5% decline over 30 days, a 7.0% decline year to date, and an 18.2% decline over the past year. The 5 year return sits at 30.0% and the 3 year return at a 6.2% decline. These moves have come as investors...

Valley National Bank, part of Valley National Bancorp (NasdaqGS:VLY), received its third consecutive Outstanding Community Reinvestment Act rating from the OCC. The new rating recognizes the bank's record on community investment, responsible lending, and support for affordable housing and small businesses. This marks three straight CRA evaluation periods with the highest rating available for the institution. For investors watching Valley National Bancorp at a share price of $13.37, this...